ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

Women’s Caucus Calls For Wide Mammogram Payment

March 18, 1994

NCI Study Tests Method For Biomarker Validation

July 24, 2009

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

Obama Calls for Bigger Investment in Science, GOP Plans Cuts

January 28, 2011

It’s “High Noon” For Cancer, Vice President Says

October 2, 1998